[ad_1]
Immunovia (OTC:IMMVF) has introduced that it will likely be hiring a brand new CFO as its focus turns to the US market. As Immunovia transitions to commercializing its check within the second half of 2025, the corporate’s monetary management wants are altering.
The launch of Immunovia’s pancreatic most cancers check within the USA creates a necessity for deeper experience and relationships within the US diagnostics market in addition to international capital markets.
Within the interim interval, monetary management obligations can be assumed by Jeff Borcherding and Immunovia finance workforce members.
The launch of Immunovia’s pancreatic most cancers check within the USA creates a necessity for deeper experience and relationships within the US diagnostics market in addition to international capital markets.
Within the interim interval, monetary management obligations can be assumed by Jeff Borcherding and Immunovia finance workforce members.
[ad_2]
Source link
